Recent updates to the widely used diagnostic and prognostic classification systems for acute myeloid leukemia (AML) poise challenges for providers in performing accurate diagnosis and evidence-based treatment selection. Of note, significant changes were made to the classification of secondary AML (sAML), in which previously defined myelodysplastic-related changes (AML-MRC) and therapy-related AML (t-AML) categories were removed and replaced with diagnostic qualifieris such as myelodysplasia-related gene mutations that are irrespective of prior malignancy. Are you ready to apply these updates to treatment decisions? Test your knowledge and clinical acumen for diagnosing and managing sAML with this bite-sized booster quiz.
- Provider:PRIME Education, Inc. (PRIME®)
- Activity Link: https://primeinc.org/online/updates-aml-classification-treatment-paradigm
- Start Date: 2024-05-10 05:00:00
- End Date: 2024-05-10 05:00:00
- Credit Details: AAPA Category 1 Credit™️: 0.25 hours
AMA PRA Category 1 Credit™️: 0.25 hours
Nursing: 0.25 hours
Pharmacy: 0.25 hours - MOC Credit Details: ABIM - 0.25 Point; Credit Type(s): Medical Knowledge (ABIM)
- Commercial Support: Source: Jazz Pharmaceuticals, Inc. - Amount: 33166.67 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner Knowledge, Learner/Team Competence
- Provider Ship: Directly Provided
- Registration: Open to all
- Specialty: Hematology, Medical Oncology
Subscribe
Login
0 Comments
Oldest